Mikael Loschi

27PUBLICATIONS
170CO-AUTHORS
Transplantation immunologyCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Cardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 12, 2026
GVHD prophylaxis with PTCy, ATG, PTCy+ATG, or no in vivo T-cell depletion in RIC matched-donor PBSC transplantation for AML and MDS.

|Aug 21, 2026
Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.

|Jun 02, 2026
Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

|Apr 01, 2026
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee.

Christopher Armstrong, Kavita Raj, Giorgia Battipaglia

|Oct 22, 2025
Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry.

Federico Erbella, Emmanuel Bachy, Guillaume Cartron

|Sep 15, 2025
Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TC.

Maxime Jullien, Eolia Brissot, Etienne Daguindau

Pageof 5

Frequent Collaborators

10 joint publications

Edouard Forcade

8 joint publications

Marie Robin

6 joint publications

Raynier Devillier

6 joint publications

Emmanuel Bachy